Fabio Uribe
⚠️ Moderate Risk
FEI: 3003572260 • Bogota • COLOMBIA
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
AGR RX
The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 5/2/2002 | 62GCB18DICLOFENAC SODIUM (ANTI-INFLAMMATORY) | 179AGR RX | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Fabio Uribe's FDA import refusal history?
Fabio Uribe (FEI: 3003572260) has 1 FDA import refusal record(s) in our database, spanning from 5/2/2002 to 5/2/2002.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Fabio Uribe's FEI number is 3003572260.
What types of violations has Fabio Uribe received?
Fabio Uribe has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Fabio Uribe come from?
All FDA import refusal data for Fabio Uribe is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.